We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+11.11%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$338B
AUM Growth
+$13.2B
Cap. Flow
-$8.05B
Cap. Flow %
-2.38%
Top 10 Hldgs %
23.21%
Holding
3,478
New
75
Increased
881
Reduced
2,243
Closed
162

Sector Composition

Rank Sector Weight
1 Technology 26.36%
2 Consumer Discretionary 12.42%
3 Healthcare 12.26%
4 Financials 12.2%
5 Communication Services 8.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VATE icon
2876
INNOVATE Corp
VATE
$165M
$942K ﹤0.01%
26,116
-16,153
-38% -$642K
JOAN
2877
DELISTED
JOANN, Inc. Common Stock
JOAN
$942K ﹤0.01%
99,593
+22,571
+29% +$236K
SGC icon
2878
Superior Group of Companies
SGC
$225M
$941K ﹤0.01%
45,055
-3,093
-6% -$73.7K
ICVX
2879
DELISTED
Icosavax, Inc. Common Stock
ICVX
$935K ﹤0.01%
43,755
-2,166
-5% -$55.9K
CURO
2880
DELISTED
CURO Group Holdings Corp.
CURO
$928K ﹤0.01%
60,719
-5,644
-9% -$98.2K
COGT icon
2881
Cogent Biosciences
COGT
$7.24B
$926K ﹤0.01%
116,607
-9,458
-8% -$82.2K
BRBS icon
2882
Blue Ridge Bankshares
BRBS
$332M
$919K ﹤0.01%
51,145
-7,507
-13% -$136K
EEM icon
2883
iShares MSCI Emerging Markets ETF
EEM
$29.5B
$912K ﹤0.01%
19,052
-2,752,625
-99% -$138M
TACO
2884
DELISTED
Del Taco Restaurants, Inc. Common Stock
TACO
$908K ﹤0.01%
120,541
-14,076
-10% -$136K
URGN icon
2885
UroGen Pharma
URGN
$2.29B
$906K ﹤0.01%
93,752
-6,564
-7% -$92.5K
LXRX icon
2886
Lexicon Pharmaceuticals
LXRX
$1.1B
$904K ﹤0.01%
242,353
-340,947
-58% -$1.66M
HBMD
2887
DELISTED
Howard Bancorp, Inc. Common Stock
HBMD
$903K ﹤0.01%
42,820
-6,498
-13% -$139K
ACTG icon
2888
Acacia Research
ACTG
$470M
$901K ﹤0.01%
189,222
-21,507
-10% -$116K
CBAY
2889
DELISTED
Cymabay Therapeutics
CBAY
$897K ﹤0.01%
282,669
-23,178
-8% -$88K
AVTR.PRA
2890
DELISTED
Avantor, Inc. Series A Mandatory Convertible Preferred Stock
AVTR.PRA
0
CCB icon
2891
Coastal Financial
CCB
$693M
$884K ﹤0.01%
21,142
-6,450
-23% -$267K
NPKI
2892
NPK International
NPKI
$1.14B
$880K ﹤0.01%
329,873
-267,313
-45% -$858K
STTK icon
2893
Shattuck Labs
STTK
$694M
$877K ﹤0.01%
103,021
-2,010
-2% -$27.7K
VRA icon
2894
Vera Bradley
VRA
$98.7M
$876K ﹤0.01%
105,308
-6,593
-6% -$63.4K
CVM icon
2895
CEL-SCI Corp
CVM
$30.1M
$869K ﹤0.01%
3,885
-335
-8% -$103K
CUE icon
2896
Cue Biopharma
CUE
$114M
$868K ﹤0.01%
2,777
-374
-12% -$145K
AKTS
2897
DELISTED
Akoustis Technologies Inc
AKTS
$864K ﹤0.01%
128,388
-7,155
-5% -$53.4K
RCEL icon
2898
Avita Medical
RCEL
$240M
$862K ﹤0.01%
73,228
-4,585
-6% -$69.9K
STR
2899
DELISTED
Sitio Royalties
STR
$862K ﹤0.01%
49,392
-5,186
-10% -$111K
CCRD
2900
DELISTED
CoreCard
CCRD
$860K ﹤0.01%
21,981
-15,816
-42% -$658K

Similar funds

Nuveen's Q4 2021 Portfolio in Review

As of Q4 2021, Nuveen held 3,478 positions worth $338B, up 4.1% from $325B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Nuveen's Q4 2021 filing shows 75 new, 881 increased, 2,243 reduced and 162 closed positions. Its largest new stake was Roblox: 1,368,944 shares worth $141M. The largest sale was iShares Russell 1000 Growth ETF, an estimated $1.18B.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Nuveen's largest Q4 2021 buy was Roblox: 1,368,944 shares worth $141M.
  • Nuveen added most to Nuveen Growth Opportunities ETF in Q4 2021, an estimated $3.24B increase.
  • Nuveen's biggest Q4 2021 reduction was iShares Russell 1000 Growth ETF, cutting an estimated $1.18B.
  • Nuveen fully exited CIMAREX ENERGY CO in Q4 2021, selling an estimated $102M.
  • Nuveen's ten largest holdings make up 23% of its $338B portfolio in Q4 2021.
  • Nuveen opened 75 new positions and closed 162 in Q4 2021.
  • Nuveen's portfolio value rose 4.1% quarter-over-quarter to $338B.

Based on Nuveen's 13F filing for Q4 2021, filed 14 Feb 2022.